Armando Santoro, MD

Niraparib and Temozolomide in Patients Glioblastoma

Role: lead

Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)

Role: lead

Pemetrexed in Advanced Non-small Cell Lung Cancer

Role: lead

Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients

Role: lead

Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients

Role: lead

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

Role: lead

Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy

Role: lead

Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients

Role: lead

Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects

Role: lead

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Role: lead

Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection

Role: lead

Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma

Role: lead

Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients

Role: lead

Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation

Role: lead

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Role: lead

Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLC

Role: lead

Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients

Role: lead

Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma

Role: lead